Fischer Medical Ventures Ltd (Fisher MVL), a leading Indian manufacturer of high-quality Magnetic Resonance Imaging (MRI) systems, has announced a groundbreaking global partnership with The Therapy Platform PTE. Ltd. This strategic alliance signifies a shared commitment to revolutionising mental healthcare via the power of advanced technology and innovative solutions.
Fischer Medical Ventures Ltd, formerly known as Fischer Chemic Limited, has developed itself as a frontrunner in the Indian healthcare sector. It holds the distinction of being the first company in India to indigenously manufacture advanced MRI systems through its wholly-owned subsidiary, Time Medical International Ventures (India) Private Limited. After careful evaluation, FIsher MVL has chosen The Therapy Platform as its exclusive global partner to bring diagnostic solutions to market.
The Therapy Platform: Empowering Mental Wellness
The Therapy Platform is a Singapore-based mental health technology company dedicated to enhancing the quality and accessibility of psychological counselling services. Their mission is threefold:
This partnership exemplifies a powerful synergy between cutting-edge technology and a deep understanding of mental health needs. Fischer Medical Ventures and The Therapy Platform share a commitment to:
With the global mental health market projected to reach USD 530.5 billion by 2032 (USD 399.7 billion in 2023), this strategic alliance arrives at a critical juncture. Together, both companies aim to make a lasting positive impact on the lives of millions by staying at the forefront of medical technology and fostering greater accessibility to mental health resources, all while maintaining a focus on affordability and quality.
“Our alliance with The Therapy Platform underscores our commitment to invest in mental healthcare solutions. We consider this sector as essential healthcare yet heavily under-served and intend to take global leadership in this space. By harnessing the power of AI and cutting-edge technology, we aim to offer comprehensive diagnostic and monitoring solutions that can empower healthcare providers and patients to take control of their mental health journey while reducing the burden on the caregivers and society,” said Mr Ravindran Govindan, Chairman & Managing Director of Fischer MVL.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Jun 5, 2024, 4:22 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates